Literature DB >> 22537333

Syncope and exercise-related ventricular tachycardia.

James Gallagher1, David T Huang, Arthur A M Wilde, Spencer Z Rosero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22537333      PMCID： PMC6932304          DOI： 10.1111/j.1542-474X.2012.00487.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN： 1082-720X            Impact factor:   1.468


× No keyword cloud information.
  8 in total

1.  Purkinje cell calcium dysregulation is the cellular mechanism that underlies catecholaminergic polymorphic ventricular tachycardia.

Authors:  Todd J Herron; Michelle L Milstein; Justus Anumonwo; Silvia G Priori; José Jalife
Journal:  Heart Rhythm       Date:  2010-06-09       Impact factor: 6.343

2.  Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands.

Authors:  Raymond W Sy; Christian van der Werf; Ishvinder S Chattha; Priya Chockalingam; Arnon Adler; Jeffrey S Healey; Mark Perrin; Michael H Gollob; Allan C Skanes; Raymond Yee; Lorne J Gula; Peter Leong-Sit; Sami Viskin; George J Klein; Arthur A Wilde; Andrew D Krahn
Journal:  Circulation       Date:  2011-10-31       Impact factor: 29.690

3.  Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death.

Authors:  N Sumitomo; K Harada; M Nagashima; T Yasuda; Y Nakamura; Y Aragaki; A Saito; K Kurosaki; K Jouo; M Koujiro; S Konishi; S Matsuoka; T Oono; S Hayakawa; M Miura; H Ushinohama; T Shibata; I Niimura
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

4.  Early repolarization: electrocardiographic phenotypes associated with favorable long-term outcome.

Authors:  Jani T Tikkanen; M Juhani Junttila; Olli Anttonen; Aapo L Aro; Samuli Luttinen; Tuomas Kerola; Solomon J Sager; Harri A Rissanen; Robert J Myerburg; Antti Reunanen; Heikki V Huikuri
Journal:  Circulation       Date:  2011-05-31       Impact factor: 29.690

5.  Clinical effectiveness of pulmonary vein isolation for arrhythmic events in a patient with catecholaminergic polymorphic ventricular tachycardia.

Authors:  Naokata Sumitomo; Takahiro Nakamura; Junji Fukuhara; Toshiko Nakai; Ichiro Watanabe; Hideo Mugishima; Masayasu Hiraoka
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

6.  Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.

Authors:  Christian van der Werf; Prince J Kannankeril; Frederic Sacher; Andrew D Krahn; Sami Viskin; Antoine Leenhardt; Wataru Shimizu; Naokata Sumitomo; Frank A Fish; Zahurul A Bhuiyan; Albert R Willems; Maurits J van der Veen; Hiroshi Watanabe; Julien Laborderie; Michel Haïssaguerre; Björn C Knollmann; Arthur A M Wilde
Journal:  J Am Coll Cardiol       Date:  2011-05-31       Impact factor: 24.094

Review 7.  Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments.

Authors:  Christian van der Werf; Aeilko H Zwinderman; Arthur A M Wilde
Journal:  Europace       Date:  2011-09-04       Impact factor: 5.214

8.  The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.

Authors:  Argelia Medeiros-Domingo; Zahurul A Bhuiyan; David J Tester; Nynke Hofman; Hennie Bikker; J Peter van Tintelen; Marcel M A M Mannens; Arthur A M Wilde; Michael J Ackerman
Journal:  J Am Coll Cardiol       Date:  2009-11-24       Impact factor: 24.094
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.